The Strategic Imbalance in the U.S. CHIPS Act Execution
While the U.S. pours billions into physical fabrication capacity, the GAO warns that R&D funding remains stagnant, threatening the long-term viability of the domestic semiconductor ecosystem.
The U.S. semiconductor strategy, codified in the 2022 CHIPS and Science Act, is currently undergoing a painful reality check. While billions of dollars have flowed into the construction of massive fabrication plants across the country, a recent Government Accountability Office (GAO) report highlights a glaring imbalance in the execution of this industrial policy. The focus has been almost exclusively on physical capacity—the concrete, cleanrooms, and lithography tools—while the foundational R&D that actually keeps a nation at the bleeding edge of silicon design has been systematically neglected. For engineers tasked with deploying these technologies, the signal is clear: the U.S. is building the body of a giant while starving its brain.
This imbalance creates a precarious situation for the domestic industry. By prioritizing manufacturing volume over research, the policy risks creating a cluster of high-cost facilities that could quickly become obsolete if they are tethered to aging process technologies. Semiconductor leadership is not just about the number of wafers that can be produced in a given quarter; it is about the ability to innovate at the transistor level, optimize power delivery, and pioneer new packaging techniques. Without significant, sustained investment in R&D, these new facilities may struggle to compete with established foundries in East Asia that have spent decades refining both their manufacturing rigor and their deep-tech research pipelines.
The competitive landscape is shifting rapidly, and the U.S. approach seems to assume that manufacturing proximity is a panacea for all supply chain vulnerabilities. However, the complexity of modern chip design—ranging from advanced gate-all-around transistors to heterogeneous integration—requires an ecosystem that thrives on constant, iterative research. When federal funding is directed primarily toward capital expenditure (CapEx) for fabs rather than the operational expenditure (OpEx) of research labs and academic partnerships, the industry loses the ability to pivot when the next paradigm shift arrives. We are essentially subsidizing the status quo while the rest of the world continues to invest in the next architecture.
Looking ahead, the industry must watch for a potential pivot in federal funding priorities or risk a 'hollow' manufacturing sector. If the current trend continues, we may see a scenario where the U.S. possesses significant domestic capacity for legacy nodes, yet remains entirely dependent on foreign innovation for cutting-edge AI and high-performance computing silicon. This is a strategic failure that no amount of government-subsidized floor space can fix. The challenge for policymakers is to recognize that a fab is only as valuable as the innovation it enables, and that the true value of the semiconductor industry lies in the intellectual property that precedes the wafer.
Furthermore, the reliance on external R&D to fill the gap left by domestic underinvestment is becoming increasingly risky as global export controls and geopolitical tensions tighten. If the U.S. cannot foster a self-sustaining cycle of innovation that moves from university labs to pilot lines and finally to full-scale production, it will remain tethered to global partners that are increasingly viewing their own intellectual property as a strategic weapon. The focus must shift from merely 'building' to 'inventing' if the domestic industry hopes to remain relevant in the face of rapid technological acceleration and the inevitable commoditization of older manufacturing processes.
Ultimately, the success of the CHIPS Act will not be measured by the number of ribbon-cutting ceremonies at new plant sites, but by the density of innovation occurring within those walls. Engineers and industry leaders should be wary of a strategy that prioritizes short-term manufacturing optics over long-term research viability. The next phase of this policy must address the R&D deficit directly, perhaps by incentivizing deeper collaboration between the newly funded fabs and the research institutions that have historically driven the field forward. Without this correction, the U.S. risks building a monumental infrastructure for a future that it is no longer equipped to define.
Sources
- 01 The U.S. Is Building CHIPS Act Fabs but Neglecting R&D — IEEE Spectrum — Semiconductors